Subscribe to our feed.

Phase 2b TARGET trial results show improved survival in NSCLC patients

September 27, 2014 — - Data Presented Today as Late-Breaker at European Society for Medical Oncology (ESMO) 2014 Congress in Madrid -- Interim Update of Overall Survival Analysis Shows 30 Percent Reduction of Risk of Death in Pre-Defined Adenocarcinoma Patient Subgroup - - Conference Call/Webcast at 8:30 a.m. EDT Monday, Sept. 29 - Read More

Two national agriculture industry leaders partner on precision planting high-tech platform to increase crop yields

September 25, 2014 — WEST LAFAYETTE, Ind. and WESTFIELD, Ind. — AgReliant Genetics LLC, a leader in seed research, production and quality and the third largest corn seed company in the U.S., and Spensa Technologies Inc., a multiplatform agriculture services company based in the Purdue Research Park, signed an agreement that will help growers integrate innovative and precision planting tools with AgReliant hybrid information to improve overall crop production. Read More